Terveystalo aims to enhance its mental health service portfolio by acquiring Recuror Oy, a pioneer in psychiatric services and neuromodulation treatments.
Information on the Target
Terveystalo has announced its intention to acquire the entire share capital of Recuror Oy as of May 30, 2025. This strategic acquisition aims to enhance Terveystalo's mental health service portfolio, particularly in the cities of Turku and Helsinki, as well as expanding its offerings through digital platforms nationwide.
Founded in 2021, Recuror Oy is recognized for its specialized psychiatric services and is at the forefront of innovative neuromodulation treatments designed to address conditions such as depression and chronic pain. In the fiscal year 2024, Recuror achieved net sales amounting to €2.5 million, showcasing its potential for growth in the mental health sector.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Finland
Finland's mental health services industry is evolving rapidly, driven by increasing awareness and acceptance of mental health issues among the population. The demand for mental health services has surged in recent years, high
Similar Deals
Hammas Hohde Oy → Hammasklinikka Kruunu Oy
2025
PlusTerveys Hammasklinikat Oy → Hyggan klinikkaliiketoiminta
2025
Terveystalo
invested in
Recuror Oy
in 2025
in a Other deal
Disclosed details
Revenue: $3M